139 related articles for article (PubMed ID: 29277790)
1. Protein Expression and Genetic Variation of
Shamoun L; Kolodziej B; Andersson RE; Dimberg J
Anticancer Res; 2018 Jan; 38(1):321-328. PubMed ID: 29277790
[TBL] [Abstract][Full Text] [Related]
2. Role of cytokine gene polymorphisms in gastric cancer risk in Chile.
Gonzalez-Hormazabal P; Musleh M; Bustamante M; Stambuk J; Escandar S; Valladares H; Lanzarini E; Chiong H; Rojas J; Castro VG; Rubio-Reyes C; Jara L; Berger Z
Anticancer Res; 2014 Jul; 34(7):3523-30. PubMed ID: 24982364
[TBL] [Abstract][Full Text] [Related]
3. CD93 gene polymorphism is associated with disseminated colorectal cancer.
Olsen RS; Lindh M; Vorkapic E; Andersson RE; Zar N; Löfgren S; Dimberg J; Matussek A; Wågsäter D
Int J Colorectal Dis; 2015 Jul; 30(7):883-90. PubMed ID: 26008729
[TBL] [Abstract][Full Text] [Related]
4. Gene polymorphism of matrix metalloproteinase-12 and -13 and association with colorectal cancer in Swedish patients.
VAN Nguyen S; Skarstedt M; Löfgren S; Zar N; Andersson RE; Lindh M; Matussek A; Dimberg J
Anticancer Res; 2013 Aug; 33(8):3247-50. PubMed ID: 23898086
[TBL] [Abstract][Full Text] [Related]
5. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variants of the
Dimberg J; Shamoun L; Landerholm K; Andersson RE; Kolodziej B; Wågsäter D
Anticancer Res; 2019 Sep; 39(9):4933-4940. PubMed ID: 31519598
[TBL] [Abstract][Full Text] [Related]
7. Association study on IL-4, IL-4Rα and IL-13 genetic polymorphisms in Swedish patients with colorectal cancer.
Shamoun L; Skarstedt M; Andersson RE; Wågsäter D; Dimberg J
Clin Chim Acta; 2018 Dec; 487():101-106. PubMed ID: 30227113
[TBL] [Abstract][Full Text] [Related]
8. VEGF polymorphisms may be associated with susceptibility to colorectal cancer: a case-control study.
Antonacopoulou AG; Kottorou AE; Dimitrakopoulos FI; Triantafyllia V; Marousi S; Koutras A; Kalofonos HP
Cancer Biomark; 2011; 10(5):213-7. PubMed ID: 22699782
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphism in DNA repair genes XRCC1 and XRCC6 and association with colorectal cancer in Swedish patients.
Dimberg J; Skarstedt M; Slind Olsen R; Andersson RE; Matussek A
APMIS; 2016 Sep; 124(9):736-40. PubMed ID: 27328741
[TBL] [Abstract][Full Text] [Related]
11. Expression and Polymorphism of TSLP/TSLP Receptors as Potential Diagnostic Markers of Colorectal Cancer Progression.
Semlali A; Almutairi MH; Alamri A; Reddy Parine N; Arafah M; Almadi MA; Aljebreen AM; Alharbi O; Azzam NA; Almutairi R; Alanazi M; Rouabhia M
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573368
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer.
Ungerbäck J; Belenki D; Jawad ul-Hassan A; Fredrikson M; Fransén K; Elander N; Verma D; Söderkvist P
Carcinogenesis; 2012 Nov; 33(11):2126-34. PubMed ID: 22843550
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of tumor necrosis factor alpha in Middle Eastern population with colorectal cancer.
Hamadien MA; Khan Z; Vaali-Mohammed MA; Zubaidi A; Al-Khayal K; McKerrow J; Al-Obeed O
Tumour Biol; 2016 Apr; 37(4):5529-37. PubMed ID: 26572151
[TBL] [Abstract][Full Text] [Related]
14. Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans.
Jang MJ; Jeon YJ; Kim JW; Cho YK; Lee SK; Hwang SG; Oh D; Kim NK
Mol Carcinog; 2013 Nov; 52 Suppl 1():E60-9. PubMed ID: 23169005
[TBL] [Abstract][Full Text] [Related]
15. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.
Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J
World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898
[TBL] [Abstract][Full Text] [Related]
16. Association between interleukin-32 gene polymorphism and susceptibility to preeclampsia.
Mazlum F; Gharesi-Fard B; Hadinedoushan H; Bakhshizadeh Ghashti Y
Hypertens Pregnancy; 2021 Aug; 40(3):218-225. PubMed ID: 34346819
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients.
Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
Int J Colorectal Dis; 2007 Oct; 22(10):1195-200. PubMed ID: 17611763
[TBL] [Abstract][Full Text] [Related]
18. A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma.
Plantinga TS; Costantini I; Heinhuis B; Huijbers A; Semango G; Kusters B; Netea MG; Hermus AR; Smit JW; Dinarello CA; Joosten LA; Netea-Maier RT
Carcinogenesis; 2013 Jul; 34(7):1529-35. PubMed ID: 23486016
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of the chemokine CCL21 in human colorectal adenocarcinomas.
Mumtaz M; Wågsäter D; Löfgren S; Hugander A; Zar N; Dimberg J
Oncol Rep; 2009 Jan; 21(1):153-8. PubMed ID: 19082456
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor gene polymorphisms and colorectal cancer risk: a meta-analysis.
Zhou LP; Luan H; Dong XH; Jin GJ; Man DL; Shang H
Genet Mol Res; 2011 Oct; 10(4):3674-88. PubMed ID: 22058001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
